AUGUST 2010
WWW.OBGYN-INFERTILITY-NURSE.COM
VOL 2, NO 4
e CLINIC PROFILE
EMERGING QUESTIONS
Women’s Health Specialists
What Is the Safest Contraceptive Method for Your Patient?
Interview with Lisa DeMartini and Eileen Schnitger Ms DeMartini is Clinic Administrator, and Ms Schnitger is Public Policy Director, Women’s Health Specialists, Sacramento, CA.
The CDC Issues New Practice Guidelines By Caroline Helwick
O
n May 28, 2010, the Centers for Disease Control and Prevention (CDC) issued new practice guidelines for the safe use of contraceptives.1 These are recommendations for or against certain contraceptive methods according to the patient characteristics and specific medical conditions. Based on World Health Organization (WHO) recommendations,2 the document was modified for US practitioners and their
patients. The guidelines were developed by OB/GYNs, pediatricians, family physicians, nurse-midwives, nurse practitioners, epidemiologists, and other experts. Many factors should be considered when choosing the appropriate contraceptive. The CDC practice guidelines focus primarily on the safety of a given modality for an individual but do not necessarily imply that the method is the best choice for that person. Other Continued on page 6
SPOTLIGHT From left: Lisa DeMartini and Eileen Schnitger, Women’s Health Specialists.
W
omen’s Health Specialists, the Feminist Women’s Health Centers of California, has a mission of putting “women’s health into women’s hands.” Established more than 30 years ago, the clinic continues to provide a unique approach to care by empowering women to make their own healthcare decisions based on their individual needs. Along with that, the clinic offers a lot of health education about sexually transmitted diseases (STDs), pregnancy, and pregnancy prevention. The
practitioners there see about 900 to 1000 women and men each week— about 50,000 a year in 4 clinic locations combined. The OB/GYN and Infertility Nurse asked Lisa DeMartini and Eileen Schnitger to discuss their clinic.
What does it mean to be a feminist women’s health center? A feminist health center means we keep the woman’s experience at the forefront of her visit. We evaluate her needs—her whole visit and her whole life is brought together to make sure Continued on page 10
Simple Intervention Boosts Sperm Cryopreservation in Men with Cancer By Jill Stein
A
n hour-long lecture by a fertility specialist during oncology grand rounds dramatically improves the rate of pretreatment sperm cryopreservation in young men with cancer, according to data presented at
the American Urological Association 2010 Annual Scientific Meeting. The researchers found that educating oncologists by a urologist specializing in male infertility increased sperm cryopreservation in male cancer Continued on page 26
The Official Publication of
We thank Watson Pharmaceuticals, Inc., for their gold level support. ©2010 Novellus Healthcare Communications, LLC
New Diagnostic Criteria for Gestational Diabetes Focus on Risk of Pregnancy Outcomes By Wayne Kuznar
T
he diagnosis and treatment of gestational diabetes are undergoing changes as more evidence is accumulating on the adverse risk of this condition on pregnancy outcomes, said Donna Jornsay, RN, BSN, PNP-C, CDE, a diabetes educator at Long Island Jewish Medical Center, NY, at the 2010 annual meeting of the American Diabetes Association (ADA). Previous ADA diagnostic criteria for gestational diabetes did not consider perinatal outcomes, Ms Jornsay said. But as new analyses of the data from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study have recently become available, the ap-
proach to gestational diabetes is being revised, based on the understanding that maternal hyperglycemia, although less severe than type 2 diabetes, still poses increased risk for adverse pregnancy outcomes. In 2009, a task force of the International Association of Diabetes and Pregnancy Study Groups recommended that the diagnosis of gestational diabetes be made when a pregnant woman meets 1 or more of the following criteria: • Fasting plasma glucose of 92 mg/dL • 1-hour plasma glucose of 180 mg/dL • 2-hour plasma glucose of 153 mg/dL. These new diagnostic criteria are based on their predictive value for Continued on page 8
Inside The OBGYN Nurse Recognizing Sexual Abuse, Page 8 Pharmacy Corner Progesterone-Based 17P for Preterm Prevention, Page 16 ACOG Highlights Preterm Birth Update, Page 17
The Infertility Nurse New Method to Predict IVF Success, Page 24 The Urology Nurse BPH Drug for Ejaculatory Dysfunction, Page 26 Nutrition Omega-3 Fish Oil for Major Depression, Page 27